Gré P.M. Luyten
- Ophthalmology top 0.5%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Oncology top 10%
- Immunology top 10%
- Co-authors
- Martine J. JagerGabriël van RijPieter A. van der VeldenMonika LandeszPaul MulderSharmila S. BoekhoornAnnelies de KleinRuchi Saxena
- Topics
- Ocular Oncology and Treatments (23 papers)Immunotherapy and Immune Responses (7 papers)Cutaneous Melanoma Detection and Management (7 papers)
- Partner nations
- NetherlandsUnited StatesChina
In The Last Decade
Gré P.M. Luyten
33 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Ophthalmology 784
- Molecular Biology 364
- Radiology, Nuclear Medicine and Imaging 364
- Oncology 319
- Immunology 240
Countries citing papers authored by Gré P.M. Luyten
This map shows the geographic impact of Gré P.M. Luyten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gré P.M. Luyten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gré P.M. Luyten more than expected).
Fields of papers citing papers by Gré P.M. Luyten
This network shows the impact of papers produced by Gré P.M. Luyten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gré P.M. Luyten. The network helps show where Gré P.M. Luyten may publish in the future.
Co-authorship network of co-authors of Gré P.M. Luyten
This figure shows the co-authorship network connecting the top 25 collaborators of Gré P.M. Luyten. A scholar is included among the top collaborators of Gré P.M. Luyten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gré P.M. Luyten. Gré P.M. Luyten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | Expression of immune checkpoint LAG3 is associated with high risk uveal melanoma | 1 |
| 3 | 33 | |
| 4 | 1 | |
| 5 | 14 | |
| 6 | 25 | |
| 7 | 84 | |
| 8 | 58 | |
| 9 | 6 | |
| 10 | 32 | |
| 11 | 40 | |
| 12 | 12 | |
| 13 | 9 | |
| 14 | 76 | |
| 15 | 46 | |
| 16 | 116 | |
| 17 | 39 | |
| 18 | 15 | |
| 19 | Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines. | 16 |
| 20 | 23 |
About Gré P.M. Luyten
Gré P.M. Luyten is a scholar working on Ophthalmology, Oncology and Immunology, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (23 papers), Immunotherapy and Immune Responses (7 papers) and Cutaneous Melanoma Detection and Management (7 papers). The work is most often cited by research in Ophthalmology (784 citations), Radiology, Nuclear Medicine and Imaging (364 citations) and Oncology (319 citations). Gré P.M. Luyten has collaborated with scholars based in Netherlands, United States and China. Frequent co-authors include Martine J. Jager, Gabriël van Rij, Pieter A. van der Velden, Monika Landesz, Paul Mulder, Sharmila S. Boekhoorn, Annelies de Klein, Ruchi Saxena, Cornelia M. Mooy and Mieke Versluis. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.